Safety and Tolerability of the Japanese Encephalitis Vaccine IC51

NCT00605085 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2675

Enrollment

INDUSTRY

Sponsor class

Conditions

Japanese Encephalitis

Interventions

BIOLOGICAL: Japanese Encephalitis purified inactivated vaccine (IC51)
BIOLOGICAL: Placebo

Sponsor

Valneva Austria GmbH